An interventional study of omafilcon A lens and Low ADD power somofilcon A lens in Myopia, Hyperopia and Presbyopia, sponsored by CooperVision International Limited (CVIL). Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-13.
Sponsored by CooperVision International Limited (CVIL) (part of CooperCompanies) · Not applicable, Interventional, and Treatment
The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.
The aim of the study is to evaluate the overall lens satisfaction between two soft multifocal contact lenses when compared to each other after 15 minutes of daily wear each.
1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.
This study's enrollment of 67 is below the median of 78 across 923 interventional studies indexed under Myopia.
Browse Myopia studies →CooperVision International Limited (CVIL) is the lead sponsor of 138 studies on the registry; 6 are open to participants now.
Of its 74 completed or terminated interventional studies of FDA-regulated products, 66 (89%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Device: omafilcon A lens · Device: Low ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Device: omafilcon A lens · Device: Medium ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Device: omafilcon A lens · Device: High ADD power somofilcon A lens
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear low ADD power somofilcon A lens for 15 minutes.
Participants will be randomized to wear medium ADD power somofilcon A lens for 15 minutes.
Participants will be randomized to wear high ADD power somofilcon A lens for 15 minutes.
Overall lens satisfaction
Overall Impression recorded on a visual analog scale of 0 to 100 where (0=Extremely poor. Unmanageable. Cannot use lenses, 100=Excellent. Highly impressed with these lenses overall.)
Time frame: At the end of 15 minutes wear
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
CooperVision International Limited (CVIL) →